Since the European Medicines Agency (EMA) approval of omalizumab in 2005 as the first ever biologic for severe asthma, the ...

AstraZeneca (AZN) stock in focus as its antibody drug Imfinzi gains EU panel support for treating muscle-invasive bladder ...

Adding Blenrep to standard therapy prolonged progression-free survival in patients with relapsed or refractory multiple ...

Javascript is required for you to be able to read premium content. Please enable it in your browser settings.

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

“Importantly, when combined with the sites we are opening in the US, this approval from the EMA, along with the individual country committee and/or ethics approvals, for Belgium ...

Biodexa Pharmaceuticals PLC (“Biodexa” or the“Company”) (Nasdaq: BDRX), a clinical stage biopharmaceutical company developing a pipeline of innovative products for the treatment of diseases with unmet ...

today announced that the European Medicines Agency (EMA) has approved its Clinical Trial Application (CTA) to conduct its pivotal Phase 2B/3, multi-center, randomized, double-blind, placebo-controlled ...

A Royal charter amendment enabling legal executives to call themselves ’CILEX chartered paralegals’ has received approval from the Privy Council, the Chartered Institute of Legal Executives ...

In 2022, the regulator the Medicines and Healthcare products Regulatory Agency (MHRA) and the Committees of Advertising Practice (CAP) issued a joint enforcement notice about the advertising of ...

Royal Mail has launched a trial of its first-ever electric trucks in partnership with UK-based EV specialist Magtec. Supported by an £800,000 grant from Innovate UK, the two new 19-tonne vehicles ...